Blockchain Registration Transaction Record

Limula Raises $6.8M to Democratize Access to Life-Saving Cell and Gene Therapies

Life science startup Limula raises CHF6.2M ($6.8M) to advance their solution for automating cell therapy manufacturing, aiming to make 'living cures' more accessible to patients.

The news of Limula's funding is significant as it addresses the critical issue of limited access to life-saving Cell and Gene Therapy products due to complex manufacturing processes. By automating these processes, Limula's solution has the potential to make 'living cures' more widely accessible, offering hope to millions of patients with life-threatening conditions. This development marks a crucial step towards democratizing access to transformative medical treatments and could have a profound impact on the future of healthcare.